Fanconi anemia pathway defects in neoplasia: cause or effect?
Berleth
Erica S
ES
Department of Pharmacology and Therapeutics, Grace Cancer Drug Center, Roswell Park Canncer Institute, Buffalo, New York 14263, USA. erica.berleth@rowellpark.org
D005199:Fanconi Anemia / Q000378:metabolism*; D052236:Fanconi Anemia Complementation Group D2 Protein; D006801:Humans; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology; D009687:Nuclear Proteins / Q000378:metabolism*; D015398:Signal Transduction; D025801:Ubiquitin / Q000378:metabolism
C499905:FANCD2 protein, human; D052236:Fanconi Anemia Complementation Group D2 Protein; D009687:Nuclear Proteins; D025801:Ubiquitin